Nerve growth factor is a neurotrophic factor for forebrain cholinergic neurons; implications for Alzheimer's disease
- PMID: 2824691
Nerve growth factor is a neurotrophic factor for forebrain cholinergic neurons; implications for Alzheimer's disease
Abstract
Findings obtained in recent years provide strong evidence that nerve growth factor (NGF) acts as a neurotrophic factor for cholinergic neurons of the mammalian forebrain. NFG receptors are exclusively localized on these neurons in the rat and human forebrain. NGF promotes survival, fiber elongation and expression of transmitter-specific enzymes of forebrain cholinergic neurons, in vivo and in vitro. In adult rats, intraventricular injections of NGF attenuate the degeneration of these cells after experimental lesions. These findings suggest that NGF might be able to attenuate the degeneration of cholinergic neurons occurring in Alzheimer's disease.
Similar articles
-
Nerve growth factor and Alzheimer's disease.Ann Neurol. 1986 Sep;20(3):275-81. doi: 10.1002/ana.410200302. Ann Neurol. 1986. PMID: 3532929 Review.
-
Development of cholinergic pedunculopontine neurons in vitro: comparison with cholinergic septal cells and response to nerve growth factor, ciliary neuronotrophic factor, and retinoic acid.J Neurosci Res. 1988 Oct-Dec;21(2-4):365-75. doi: 10.1002/jnr.490210228. J Neurosci Res. 1988. PMID: 3216429
-
Direct, complex effects of estrogens on basal forebrain cholinergic neurons.Exp Neurol. 2005 Aug;194(2):506-22. doi: 10.1016/j.expneurol.2005.03.015. Exp Neurol. 2005. PMID: 15893308
-
Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields.Exp Neurol. 1997 Jan;143(1):162-71. doi: 10.1006/exnr.1996.6357. Exp Neurol. 1997. PMID: 9000455
-
Rationale for the planned clinical trials with nerve growth factor in Alzheimer's disease.Psychiatr Dev. 1989 Winter;7(4):297-315. Psychiatr Dev. 1989. PMID: 2487898 Review.
Cited by
-
Expressions of Axl and Tyro-3 receptors are under regulation of nerve growth factor and are involved in differentiation of PC12 cells.Neurosci Bull. 2011 Feb;27(1):15-22. doi: 10.1007/s12264-011-1042-4. Neurosci Bull. 2011. PMID: 21270900 Free PMC article.
-
Nerve Growth Factor Compromise in Down Syndrome.Front Aging Neurosci. 2021 Aug 9;13:719507. doi: 10.3389/fnagi.2021.719507. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34434101 Free PMC article. Review.
-
Three-dimensional organotypic mouse brain slices to study Alzheimer's disease pathologies: a review.Front Dement. 2025 Jul 25;4:1585124. doi: 10.3389/frdem.2025.1585124. eCollection 2025. Front Dement. 2025. PMID: 40786195 Free PMC article. Review.
-
Advances in the pharmacotherapy of Alzheimer's disease.Eur Arch Psychiatry Clin Neurosci. 1994;244(5):261-71. doi: 10.1007/BF02190379. Eur Arch Psychiatry Clin Neurosci. 1994. PMID: 7893772 Review.
-
GABAergic terminals are a source of galanin to modulate cholinergic neuron development in the neonatal forebrain.Cereb Cortex. 2014 Dec;24(12):3277-88. doi: 10.1093/cercor/bht192. Epub 2013 Jul 29. Cereb Cortex. 2014. PMID: 23897649 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical